CD44+ HNSCC cells are capable of initiating tumors that demonstrably replicate the original tumor heterogeneity in nude mice, as well as self-renewal after serial passaging in vivo [20]. The gene discussed is CD44; the disease is head and neck squamous cell carcinoma.